Thursday, May 7, 2009

Trial Drugs 'Reverse' Alzheimer's

From The BBC:

US scientists say they have successfully reversed the effects of Alzheimer's with experimental drugs.

The drugs target and boost the function of a newly pinpointed gene involved in the brain's memory formation.

In mice, the treatment helped restore long-term memory and improve learning for new tasks, Nature reports.

The same drugs - HDAC inhibitors - are currently being tested to treat Huntington's disease and are on the market to treat some cancers.

They reshape the DNA scaffolding that supports and controls the expression of genes in the brain.

Read more
....

1 comment:

Tracy@ICARAstudy said...

This type of research is exactly why clinical studies are so important.

It is important for patients and families affected by diseases such as Alzheimer’s to consider participating in clinical studies. One such study for Alzheimer’s is the ICARA (Bapi) Study (www.icarastudy.com), whose goal is to explore if an investigational drug, called Bapineuzumab, can help slow the progression of Alzheimer’s Disease. Current therapies for Alzheimer’s treat the symptoms associated with it, not the disease itself.

Clinical studies that test new treatments are the best chance we have for fighting this disease.